Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer

Expertise

Multiple myeloma; Immunotherapy

Primære forskningsområder

Peptide vaccination; Multiple myeloma

Aktuel forskning

Phase one first in human trial on peptide vaccination against PD-L1 in multiple myeloma. 

Laboratoy investigations of PD-L1 immune responses in leukapheresis products from patients with multiple myeloma. 

Mulige interessekonflikter

None

ID: 45967723